With 171 equity allocations according to his last 13F filing, Richard Chilton has an especially diversified portfolio. Here’s a look at what he had going on in Q4.
Richard Chilton’s New Acquisitions
Chilton bought into 39 new companies in a wide range of sectors during the quarter in question. The new entries, though small in absolute terms, are significant. In fact, just two of them pass the 1% allocation mark: Colgate-Palmolive Company (NYSE:CL) and Abbott Laboratories (NYSE:ABT).
Exclusive: Third Point Expands Private Equity Business With New $300 Million Fund
Dan Loeb's Third Point recently completed the first close for TPVC, its new dedicated private growth-stage fund. The $300 million fund is part of Third Point's private investing strategy. At the end of February, Third Point managed $16.5 billion overall for clients around the world. New talent According to an investor update dated March 5th Read More
Colgate-Palmolive is a household name, as the company is behind some of the best-known brands in the world. Chilton picked up 744,500 CL shares, a 1.41% stake. The company is up +5.77 since the start of Q4 and +8.4% over the past year.
Healthcare company Abbott now comprises 1.13% of Richard Chilton’s fund and is apparently having a good run, up +20.37% since the start of Q4 and +15.23% over the past 365 days. Daniel Loeb and George Soros are also investors.
Richard Chilton’s Increased Positions
Chilton increased his stakes in 33 companies, which now represent a combined 36.40% of his holdings. The investor upped his positions in iBillionaire Index assets Mastercard Inc (NYSE:MA) and Wells Fargo & Co (NYSE:WFC), as well as big names Anheuser Busch Inbev SA (ADR) (NYSE:BUD), Diageo plc (ADR) (NYSE:DGE) and The Walt Disney Company (NYSE:DIS).
Also on the billionaire’s agenda was W.R. Grace & Co. (NYSE:GRA), in which he now has a 7.12% allocation (compared to 5.99% in Q3). A mid-cap chemical company that produces specialty materials, GRA emerged from more than 12 years of bankruptcy in early February. The company’s share price is up +16.99% since October and +3308.33% over the past 10 years. Tiger Global and Ray Dalio have stakes in GRA as well.
Richard Chilton’s Decreased Positions
Last quarter, Richard Chilton decreased his stakes in 92 companies – more than 50% of all of his allocations.
He scaled back his second and third largest positions, Dollar General Corp. (NYSE:DG) – an iBillionaire Index constituent – and Sherwin Williams (NYSE:SHW). They now compose 3.70% and 3.35% of his fund, respectively, down from 4.07% and 3.97% the previous quarter.
Richard Chilton’s Sold Out Positions
Richard Chilton cashed out 14 positions during Q4, wiping out 5.43% of his portfolio. Among the stocks he let go of were Copa Holdings, S.A. (NYSE:CPA) and Genesco Inc. (NYSE:GCO).
See Richard Chilton’s entire portfolio here.